Citius Pharmaceuticals
CTXR
22 hedge funds and large institutions have $1.85M invested in Citius Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 5 closing their positions.
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
70% more capital invested
Capital invested by funds: $1.09M → $1.85M (+$759K)
38% more funds holding
Funds holding: 16 → 22 (+6)
0.05% more ownership
Funds ownership: 0.08% → 0.13% (+0.05%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$190K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$177K |
| 3 |
WAS
Wealth Advisory Solutions
Indiianapolis,
Indiana
|
+$110K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$107K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$49.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$92K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9K |
| 3 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$2K |
| 4 |
FFA
Founders Financial Alliance
Raleigh,
North Carolina
|
-$1K |
| 5 |
FCA
FinTrust Capital Advisors
Greenville,
South Carolina
|
-$2 |
CTXR Hedge Fund Activity: Q4 2020 in Review
22 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Citius Pharmaceuticals (CTXR) for Q4 2020, worth a combined $1.85M — up 70% from $1.09M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new CTXR positions and 5 closed out — a net gain of 6 holders — while 6 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, adding an estimated $190K. The largest seller was Sabby Management, exiting entirely with an estimated $92K sold.
- 22 institutional investors held Citius Pharmaceuticals (CTXR) as of Q4 2020, up from 16 in Q3 2020.
- Funds reported $1.85M of Citius Pharmaceuticals stock for Q4 2020, up 70% quarter-over-quarter.
- 11 funds opened new Citius Pharmaceuticals positions in Q4 2020 and 5 closed out, a net change of +6 holders.
- The largest Citius Pharmaceuticals buyer in Q4 2020 was Vanguard Group, an estimated $190K added.
- The largest Citius Pharmaceuticals seller in Q4 2020 was Sabby Management, an estimated $92K sold.
Based on aggregated 13F filings for Q4 2020.